Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma

Transplantation

Volumn 80, Issue 1, 2005, Pages 88-94

  Sutcliffe, Robert ^a   Maguire, Donal ^a   Murphy, Philip ^a   Portmann, Bernard ^a   Rela, Mohamed ^a   O'Sullivan, Gerald ^b   Mufti, Ghulam ^a   Heaton, Nigel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Micrometastases

Indexed keywords

ALPHA FETOPROTEIN; GLYPICAN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE MARROW MICROMETASTASIS; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

ACTINS; ADULT; AGED; BASE SEQUENCE; BIOPSY, NEEDLE; BONE MARROW; CADAVER; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; FEMALE; HEMATOLOGIC DISEASES; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE DONORS;

EID: 22144476857     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000164499.40952.C8     Document Type: Article

References (36)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334(11): 693.
2. Philosophe B, Greig PD, Hemming AW, et al. Surgical management of hepatocellular carcinoma: Resection or transplantation? J Gastrointest Surg 1998; 2(1): 21.
3. De Carlis L, Giacomoni A, Pirotta V, et al. Treatment of HCC: The role of liver resection in the era of transplantation. Transplant Proc 2001; 33(1-2): 1453.
4. Tamura S, Kato T, Berho M, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136(1): 25.
5. Otto G, Keuschen U, Hofmann WJ, et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis. Ann Surg 1998; 227(3): 424.
6. Thorban S, Roder JD, Nekarda H, et al. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: Detection and prognostic significance. World J Surg 1996; 20(5): 567.
7. Roder JD, Thorban S, Pantel K, et al. Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer. World J Surg 1999; 23(9): 888.
8. Maguire D, O'Sullivan GC, Collins JK, et al. Bone marrow micrometastases and gastrointestinal cancer detection and significance. Am J Gastroenterol 2000; 95(7): 1644.
9. Braun S, Pantel K. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients. Oncologist 2001; 6(2): 125.
10. Komeda T, Fukuda Y, Sando T, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75(9): 2214.
11. Wong IH, Leung T, Ho S, et al. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 1997; 76(5): 628.
12. Kienle P, Weitz J, Klaes R, et al. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. Arch Surg 2000; 135(2): 213.
13. Mitry R, Hughes R, Dhawan A. Progress in human hepatocytes: Isolation, culture and cryopreservation. Cell Dev Biol 2002; 13: 463.
14. Wong IH, Lau WY, Leung T, et al. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/ adenoma, non-tumor liver and blood: Implications in cancer detection and monitoring. Cancer Lett 2000; 156(2): 141.
15. Miyamoto A, Fujiwara Y, Sakon M, et al. Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma. Dig Dis Sci 2000; 45(7); 1376.
16. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33(5): 1080.
17. Schutt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17(1): 324.
18. Hemming A, Nelson D, Reed A. Liver transplantation for hepatocellular carcinoma. Minerva Chir 2002; 57: 575.
19. Pantel K, Dickmanns A, Zippelius A, et al. Establishment of micrometastatic carcinoma cell lines: A novel source of tumor cell vaccines. J Natl Cancer Inst 1995; 87(15): 1162.
20. De Graaf H, Maelandssmo G, Ruud P, et al. Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: Studies on the epithelial glycoprotein gene EGP-2. Int J Cancer 1997; 722: 191.
21. Bustin SA, Gyselman VG, Siddiqi S, et al. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients. Int J Surg Invest 2000; 2(1): 49.
22. Gross HJ, Verwer B, Houck D, et al. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10 (-7). Proc Natl Acad Sci USA 1995; 92: 537.
23. Kubota H, Storms RW, Reid LM. Variant forms of alpha-fetoprotein transcripts expressed in human hematopoietic progenitors. J Biol Chem 2002; 277(31): 27629.
24. Niwa Y, Matsumura M, Shiratori Y, et al. Quantitation of alpha-feto-protein and albumin messenger RNA in human hepatocellular carcinoma. Hepatology 1996; 23(6): 1384.
25. Wennerberg A, Nalesnik M, Coleman W. Hepatocyte paraffin 1: A monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993; 143; 1050.
26. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997; 10(7): 686.
27. Capurro M, Wanless IR, Sherman M, et al. Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125(1): 89.
28. Osborne MP, Wong GY, Asina S, et al. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 1991; 51(10): 2706.
29. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology 2000; 32(1): 11.
30. Paris RA, Konkin T, Halpert G. Liver stem cells: A potential source of hepatocytes for the treatment of human liver disease. Artif Organs 2001; 25(7): 513.
31. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989; 134(6): 1347.
32. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer and cancer stem cells. Nature 2001; 414(6859): 105.
33. O'Sullivan GC, Collins JK, Kelly J, et al. Micrometastases: Marker of metastatic potential or evidence of residual disease? Gut 1997; 40(4): 512.
34. Braun S, Pantel K. Biological characteristics of micrometastatic cancer cells in bone marrow. Cancer Metastasis Rev 1999; 18(1): 75.
35. Hohaus S, et al. Persistence of isolated tumor cells in patients with breast cancer after sequential high-dose therapy with peripheral blood stem cell transplantation. Blood 1996; 88(10): 128A.
36. O'Sullivan GC, Sheehan D, Clarke A, et al. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments. Gastroenterology 1999; 116(3): 543.